Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
Hemafima AB
AB
Active
Org 5593037004
Ebbarpsvägen 58 C, 283 43
Osby
Literary creation and musical composition activities
·
NACE 9011
Est. 2021 · 5 years old
0 employees
Monitor
Share
Sweden
/
Companies
/
Literary creation and musical composition activities
/
Hemafima AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
0M
0M
0M
-1M
-1M
2021: 0M
0M
2021
2022: 0M
0M
2022
2023: 0M
0M
2023
2024: 0M
0M
2024
EBITDA
SEK millions
0M
0M
0M
-1M
-1M
2021: 0M
0M
2021
2022: 0M
0M
2022
2023: 0M
0M
2023
2024: 0M
0M
2024
Income statement
SEK thousands
Item
2024
2023
2022
2021
Revenue
275
97
85
28
Staff expenses
—
—
—
—
EBITDA
126
22
−78
−140
Depreciation & amort.
−6
−4
−0
−0
EBIT
120
18
−78
−140
Net financials
—
—
—
—
Profit before tax
120
19
−78
−140
Tax
−0
−0
−0
−0
Net profit
120
19
−78
−140
Balance sheet
SEK thousands
Item
2024
2023
2022
2021
Total assets
279
103
50
70
Equity
161
41
22
25
Long-term debt
69
56
0
45
Short-term debt
49
7
28
0
Total debt
118
63
28
45
Financial ratios
5-year trend
EBITDA margin
45,8 %
This company
15,8 %
Market median
This company
Market median
190% above market
2021
2024
Equity ratio
57,7 %
This company
38,2 %
Market median
This company
Market median
51% above market
2021
2024
Return on equity
74,5 %
This company
18,4 %
Market median
This company
Market median
305% above market
2021
2024
Net profit margin
43,6 %
This company
8,1 %
Market median
This company
Market median
438% above market
2021
2024
Asset turnover
0,99×
This company
1,12×
Market median
This company
Market median
12% below market
2021
2024
Debt / equity
0,73×
This company
0,62×
Market median
This company
Market median
18% above market
2021
2024
Annual reports & filings
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2021-02-01 – 2021-12-31
View
PDF
More on Hemafima AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
